Affiliation:
1. Alberta Transplant Applied Genomics Centre; Edmonton AB Canada
2. Department of Medicine; Division of Nephrology and Transplant Immunology; University of Alberta; Edmonton AB Canada
3. Department of Laboratory Medicine and Pathology; University of Alberta; Edmonton AB Canada
Funder
Novartis Pharma AG
Genome Canada
University of Alberta Hospital Foundation
Roche Molecular Systems
Hoffmann-La Roche Canada Ltd.
Canada Foundation for Innovation
Alberta Ministry of Advanced Education and Technology
Roche Organ Transplant Research Foundation
Astellas
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Reference60 articles.
1. The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: Where we have been, are, and will be;Sullivan;Clin Cancer Res,2013
2. T-lymphocyte-antigen interactions in transplant rejection;Krensky;N Engl J Med,1990
3. Molecular executors of cell death differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts;Sharma;Transplant,1996
4. T cell mediated rejection of kidney transplants: A personal viewpoint;Halloran;Am J Transplant,2010
5. Cognate antigen directs CD8+ T cell migration to vascularized transplants;Walch;J Clin Invest,2013
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献